FDA warns vs. 6 unregistered drug products

Published February 13, 2015 7:00am

The Food and Drug Administration has warned the public against six unregistered drug products that it recently collected from Taytay town in Rizal province.

In Advisory 2015-003, the FDA said these include:

- Thyroid USP (Westhroid TH-1/4) 16.25 mg tablet
- Phospatidylcholine + Deoxycholic acid 10%/4.75% 50 ml vial
- Lidocaine (SM Cream) 9.6% 30 g cream
- Ascorbic acid (Vitamin C injection) 500 mg/2 ml solution for injection, made by Arrow Pharma Group New Zealand
- Reduced L-Glutathione (Reiki) 600 mg powder for injection (IV/IM)
- Reduced L-Glutathione (Reiki) 1200 mg powder for injection (IV/IM)

The FDA said its field officers have orders to confiscate the unregistered drugs.

It also asked local government units and law enforcement agencies to ensure these products are not sold in their jurisdiction.

Also, it warned drug outlets against importing, distributing or selling such products. It advised consumers to buy medication from FDA-licensed establishments. — Joel Locsin/LBG, GMA News

Tags: foodanddrugadministration, fdaadvisory